Inhibition of nuclear factor-'kappa'B by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells (2012)
- Authors:
- USP affiliated authors: QUEIROZ, ROSANE GOMES DE PAULA - FMRP ; VALERA, FABIANA CARDOSO PEREIRA - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; TONE, LUIZ GONZAGA - FMRP
- Unidade: FMRP
- DOI: 10.1097/CAD.0b013e328350e835
- Subjects: OSTEOSSARCOMA (TRATAMENTO;EFEITOS DE DROGAS); NEOPLASIAS ÓSSEAS; APOPTOSE; QUIMIOTERÁPICOS (COMBINAÇÃO); ANTINEOPLÁSICOS
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2012
- Source:
- Título: Anti-Cancer Drugs
- ISSN: 0959-4973
- Volume/Número/Paginação/Ano: v. 23, n. 6, 2012
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CASTRO-GAMERO, Angel Mauricio et al. Inhibition of nuclear factor-'kappa'B by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells. Anti-Cancer Drugs, v. 23, n. 6, 2012Tradução . . Disponível em: https://doi.org/10.1097/CAD.0b013e328350e835. Acesso em: 28 jan. 2026. -
APA
Castro-Gamero, A. M., Borges, K. S., Silveira, V. da S., Lira, R. C. P., Queiroz, R. G. de P., Valera, F. C. P., et al. (2012). Inhibition of nuclear factor-'kappa'B by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells. Anti-Cancer Drugs, 23( 6). doi:10.1097/CAD.0b013e328350e835 -
NLM
Castro-Gamero AM, Borges KS, Silveira V da S, Lira RCP, Queiroz RG de P, Valera FCP, Scrideli CA, Umezawa K, Tone LG. Inhibition of nuclear factor-'kappa'B by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells [Internet]. Anti-Cancer Drugs. 2012 ; 23( 6):[citado 2026 jan. 28 ] Available from: https://doi.org/10.1097/CAD.0b013e328350e835 -
Vancouver
Castro-Gamero AM, Borges KS, Silveira V da S, Lira RCP, Queiroz RG de P, Valera FCP, Scrideli CA, Umezawa K, Tone LG. Inhibition of nuclear factor-'kappa'B by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells [Internet]. Anti-Cancer Drugs. 2012 ; 23( 6):[citado 2026 jan. 28 ] Available from: https://doi.org/10.1097/CAD.0b013e328350e835 - Protein expression of matrix metalloproteinase (MMP-1, -2, -3, -9 and -14) in Ewing family tumors and medulloblastomas of pediatric patients
- Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes in a brasilian population
- Study adrenocortical tumors in children and adolescent by technique comparative genomic hybridization (CGH)
- Role of SHOC2 gene in the chemotherapy sensibility process in childhood acute lymphoblastic leukemia
- HDAC9 over-expression correlated with adverse prognosis in acute lymphoblastic leukemia
- A simplified PCR approach for minimal residual disease (MDR) detection at early treatment points stratifies children with acute lymphoblastic leukemia (ALL) into good and poor outcome groups
- mRNA expression of NMP2 and MMP9 and TIMP1 and TIMP2 in childhood all: potential role of TIMP1 as an adverse prognostic factor
- Expression profile of a apoptosis-related genes by real-time quantitative PCR in children with acute lymphoblastic leukemia
- Expression profile of genes related to cellular migration and adhesion (TIMP-1, TIMP-2 and MMP-9) in childhood acute lymphoblastic leukemia
- Zebularine promotes radiosensitivity in glioblastoma and is less cytotoxic tham temozolomide
Informações sobre o DOI: 10.1097/CAD.0b013e328350e835 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
